Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. inflammatory process
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Inflammatory Process Articles & Analysis

6 news found

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung damage such as fibrosis. A groundbreaking study has developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), which shows significant potential as a therapeutic agent. This ...

BySCIREQ - an emka TECHNOLOGIES Company


Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Their versatility has propelled their adoption in various research pursuits, including the exploration of cancer, inflammatory processes, and infectious diseases. Moreover, lectins have garnered attention in the commercial sphere, paving the way for the development of diagnostic tools, therapeutic agents, and food additives. ...

ByCreative BioMart


Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

We believe that a successful safety study under a Phase I clinical trial can begin to open other doors that involve inflammatory processes in the field of treating neuropathic pain. While the current data regarding KLS-13019 is preclinical, the results are overwhelmingly positive and gives us a great deal of optimism for the future of our lead drug candidate. ...

ByNeuropathix, Inc.


TIKOMED’S ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in patients with ALS in data published by the Journal of Personalized Medicine

TIKOMED’S ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in patients with ALS in data published by the Journal of Personalized Medicine

The treatment response appears to be mediated by improvement of tissue bioenergetics, decrease of oxidative/nitrosative stress and attenuation of (neuro)inflammatory processes. The deranged neuronal function associated with the oxidative/nitrosative stress and mitochondrial dysfunction characterized by the pathophysiological progress of neurodegenerative ...

ByTIKOMED AB


AB2 Bio announces readiness for recruitment in pivotal Phase 3 trial of Tadekinig alfa, a novel human recombinant interleukin-18 binding protein, in children with genetic diagnosis of NLRC4-MAS mutation or XIAP deficiency, with amended design in the U.S.

AB2 Bio announces readiness for recruitment in pivotal Phase 3 trial of Tadekinig alfa, a novel human recombinant interleukin-18 binding protein, in children with genetic diagnosis of NLRC4-MAS mutation or XIAP deficiency, with amended design in the U.S.

Tadekinig alfa is a recombinant human interleukin-18 binding protein targeting the treatment of dysregulated and persistent IL-18-mediated inflammatory processes which are the basis of autoinflammatory and autoimmune diseases, such as NLRC4-MAS, XIAP deficiency, systemic Juvenile Idiopathic Arthritis, and Adult onset Still's Disease. ...

ByAB2 Bio Ltd.


Asbestos Exposure Linked to Increased Risk of Stroke, Cardiovascular Disease

Asbestos Exposure Linked to Increased Risk of Stroke, Cardiovascular Disease

However, a recent study published by Britain’s Journal of Occupational and Environmental Medicine has also linked asbestos exposure to an increased risk of stroke and cardiovascular disease due to its inflammatory properties. The study included 98,912 British men and women in the asbestos abatement and manufacturing industries where asbestos was present. ...

ByEMSL Analytical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT